Back to Search Start Over

[Urinary incontinence: new pharmacologic therapies].

Authors :
Robles García JE
Zudaire Bergera JJ
Rosell Costa D
Berián Polo JM
Source :
Revista de medicina de la Universidad de Navarra [Rev Med Univ Navarra] 2004 Oct-Dec; Vol. 48 (4), pp. 43-9.
Publication Year :
2004

Abstract

Several classes of drugs have been investigated for their efficacy in treating overactive bladder syndrome (OAB) and stress urinary incontinence (SUI). Surgery and behavioral therapies are currently the mainstay of treating SUI. However, results are also being made available about a new oral medication, Duloxetine, which appears to be clinically safe and effective for the treatment of SUI. On the other hand, a new muscarinic receptor antagonist, Solifenacin, has been shown in clinical trials to be clinically effective, safe and well tolerated for treating OAB.

Details

Language :
Spanish; Castilian
ISSN :
0556-6177
Volume :
48
Issue :
4
Database :
MEDLINE
Journal :
Revista de medicina de la Universidad de Navarra
Publication Type :
Academic Journal
Accession number :
15812946